Showing results (71-80 of 453) with videos related to
Sort By:
Pageof 46
Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2012
Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?Mitchell L Shiffman, Rafael EstebanWorld Journal of Gastroenterology|September 9, 2021
Naïve hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: A prospective studyMar Riveiro-Barciela, Cristina Marcos-Fosch, Fernando Martinez-Valle, et al.Gastroenterologia Y Hepatologia|August 5, 2014
[Hepatic encephalopathy]Juan Córdoba, Rafael Esteban MurAntiviral Research|July 20, 2011
Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter studySi-Nafa Si-Ahmed, Pierre Pradat, Roeland Zoutendijk, et al.Revista Espanola De Enfermedades Digestivas|August 31, 2022
New actors come into play against hepatitis deltaMar Riveiro-Barciela, Adriana Palom, Maria ButiLiver International : Official Journal of the International Association for the Study of the Liver|December 19, 2023
Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B studyAnna Feliu-Prius, Ana Barreira-Díaz, Ariadna Rando, et al.The Journal of Infectious Diseases|June 27, 2014
Natural history and management of hepatitis C: does sex play a role?Rachel Baden, Jürgen K Rockstroh, Maria ButiPlos One|July 1, 2016
Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta InfectionMaria Homs, Francisco Rodriguez-Frias, Josep Gregori, et al.Revista Espanola De Enfermedades Digestivas|January 29, 2021
The Screening Guidelines for Hepatitis C Virus Infection as a milestone in the path towards hepatitis C virus eliminationJosé Luis Calleja Panero, Rafael EstebanAnnals of Hepatology|June 15, 2017
A Case Report of Hepatocellular Carcinoma 5 Years After HBsAg Loss in Chronic Hepatitis Delta: How Long Surveillance is Required?Laura Escolà-Vergé, Mar Riveiro-Barciela, Maria ButiPageof 46